InvestorsHub Logo
Followers 49
Posts 8348
Boards Moderated 3
Alias Born 02/11/2008

Re: None

Saturday, 10/13/2018 12:49:50 AM

Saturday, October 13, 2018 12:49:50 AM

Post# of 21373
Little History on Sherry "wall st vet" Griswood

Anyone ever check out TapImmune? and Sherry Grisewoods history?  

ONCX could be headed down the same path and Sherry might have a history of the Rinse and Repeat R/S diluted scams?  

She was appointed to TapImmune in 2013 and within a year TapImmune did a R/S? The R/S took the company from pennies to almost $6  

But then after the R/S the company flopped and shareholders lost additional funds when TPIV sank from 6 back to a dollar?  

To make matter worse TPIV did another R/S split in late 2016 taking the price from $1 to $7 then in same fashion the company sank the price back down to a dollar?  

So TPIV uplists with a R/S to almost $8 then sinks it back down?  

TPIV might have given ONCX with a person who knows how to R/S a stock but not produce a product?  

Years in clinical trials without results?  
R/S?  
A/S Increases?  
Debt?  
Toxic Finance?  

Sound familiar? Oncolix has made there Intentions crystal clear on what they plan to do with ONCX but I wasn't certain of how they were going to get there until Sherry came aboard?  

R/S your way to huge funding all the way to Nasdaq, Only problem is how many R/S and how many shares will shareholders have left?  

If a shareholder had 100,000 shares of ONXC and they R/S 100 to 1 a shareholder would be left with 1000 shares, If they needed a second R/S at a rate of 10 to 1 a shareholder would be left with 100 shares?  

See how this works, It's as clear as the filings and Sherry is the key piece to get it done?  

This is a horror show  

IMO  

Everything I post, is In my own opinion, I don't care what you think about it, if you disagree, post it like I do. If you buy or sell stock based on what I say, your a lunatic and should not be trading. Have a great day!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.